LRRK2 and Parkinson disease: Moreover, the study of LRRK2 G2019S-associated PD (L2-PD) cases serves as an adequate proxy for the sporadic disease since their clinical course is nearly indistinguishable from that of sporadic PD patients and also share similar neuropathological changes4.